All stock reports

SUNPHARMA evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-06T04:36:08.027346+00:00

Metrics

latest_annual_period
2026-03-31
revenue
584620400000.0
net_income
115086500000.0
operating_cash_flow
124191800000.0
free_cash_flow
88098100000.0
total_assets
1087852200000.0
total_liabilities
249054800000.0
total_equity
838797400000.0
cash
97705100000.0
total_debt
Not supplied
revenue_growth
0.11190138010941375
earnings_growth
0.049604414145329345
net_margin
0.19685679801799594
roe
0.13720416873013674
debt_to_equity
Not supplied
cash_conversion
1.0791170119866362
free_cash_flow_margin
0.1506928256352327
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-1d9fd8f0f6269b6712c28a0d9c1cd43445003617b33efdb79cca2fa33efc3ce8
Policy
stock-decisions-v1
Evidence bundle hash
2554f6d3508c2503dac48f939eb643bcc144a33a428edb28dcb0ecada7b4c1a2
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: b64dd1a6551950700bca0163b363245b3379a9219c344afeb0a0904402f95c40
  • daily-price: 6929b883c3e7a5322aef0ae1c0a27ab2147f19af7add3a71afc29d92f0c32f6e
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Numerical report available. Evidence briefing is queued or awaiting retry.

Cached observations and evidence limits